Literature DB >> 20216077

Gastric juice from patients "on" acid suppressive therapy can still provoke a significant inflammatory reaction by human bronchial epithelial cells.

Veerle Mertens1, Kathleen Blondeau, Bart Vanaudenaerde, Robin Vos, Ricard Farre, Ans Pauwels, Geert Verleden, Dirk Van Raemdonck, Lieven Dupont, Daniel Sifrim.   

Abstract

BACKGROUND: Patients with reflux-related respiratory symptoms are frequently treated with proton pump inhibitors (PPI). It is unclear whether aspiration of gastric juice (GJ) from patients "on" PPI can provoke a similar bronchial inflammatory reaction than that observed in patients "off" medication. The goal of this study was to evaluate the effect of GJ from patients with and without PPI treatment on production of IL-8 by human primary bronchial epithelial cells (PBEC). STUDY: PBEC were exposed during 24 hours to GJ (1/1000) from patients "on" (n=10) and "off" (n=13) PPI and to nonacidic gastric components (pepsin and bile acids). IL-8 concentration in supernatant was measured with enzyme-linked immunosorbent assay. Endotoxin level in GJ samples was analyzed with a LAL assay.
RESULTS: Exposure of PBEC to GJ from patients "on" PPI provoked a higher production of IL-8 than GJ from patients "off" PPI [279 pg/mL (36 to 498) vs. 11 pg/mL (9 to 27)]. A correlation was found between pH of GJ and IL-8 production (r=0.659, P=0.0006). No correlation was found between IL-8 production and concentration of bile acids or pepsin. Filtration (0.20 [mu]m) of GJ from patients "on" PPI reduced IL-8 production. A positive correlation was found between IL-8 production and endotoxin levels of GJ samples (1/1000) (r=0.654, P=0.0007).
CONCLUSIONS: Exposure of bronchial epithelial cells to GJ from patients "on" PPI is able to induce high IL-8 production. These results suggest that aspiration of GJ in patients treated with PPI might still be able to provoke a significant bronchial inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20216077     DOI: 10.1097/MCG.0b013e3181d47dc4

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

1.  The prevalence and extent of gastroesophageal reflux disease correlates to the type of lung transplantation.

Authors:  Piero Marco Fisichella; Christopher S Davis; Vidya Shankaran; James Gagermeier; Daniel Dilling; Charles G Alex; Elizabeth J Kovacs; Raymond J Joehl; Robert B Love
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-02       Impact factor: 1.719

Review 2.  Recommendations for the management of idiopathic pulmonary fibrosis in South Africa: a position statement of the South African Thoracic Society.

Authors:  Coenraad F N Koegelenberg; Gillian M Ainslie; Keertan Dheda; Brian W Allwood; Michelle L Wong; Umesh G Lalloo; Mohamed S Abdool-Gaffar; Hoosain Khalfey; Elvis M Irusen
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Significance of gastroesophageal refluxate in relation to physical, chemical, and spatiotemporal characteristics in symptomatic intensive care unit neonates.

Authors:  Sudarshan R Jadcherla; Juan Peng; Chin Yee Chan; Rebecca Moore; Lai Wei; Soledad Fernandez; Carlo DI Lorenzo
Journal:  Pediatr Res       Date:  2011-08       Impact factor: 3.756

4.  Impact of feeding strategies on the frequency and clearance of acid and nonacid gastroesophageal reflux events in dysphagic neonates.

Authors:  Sudarshan R Jadcherla; Chin Yee Chan; Rebecca Moore; Manish Malkar; Christopher J Timan; Christina J Valentine
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-10-30       Impact factor: 4.016

Review 5.  A review of the role of GERD-induced aspiration after lung transplantation.

Authors:  P Marco Fisichella; Christopher S Davis; Elizabeth J Kovacs
Journal:  Surg Endosc       Date:  2011-11-15       Impact factor: 4.584

Review 6.  Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.

Authors:  Yohannes T Ghebre; Ganesh Raghu
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

7.  Extra-esophageal manifestations of gastroesophageal reflux disease: controversies between epidemiology and clicnic.

Authors:  Hamid Saber; Mostafa Ghanei
Journal:  Open Respir Med J       Date:  2012-11-02

8.  Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study.

Authors:  Misbah Baqir; Amit Vasirreddy; Ann N Vu; Teng Moua; Alanna M Chamberlain; Ryan D Frank; Jay H Ryu
Journal:  Respir Med       Date:  2021-01-22       Impact factor: 4.582

9.  Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium.

Authors:  Bryan P Hurley; Rebecca H Jugo; Ryan F Snow; Tina L Samuels; Lael M Yonker; Hongmei Mou; Nikki Johnston; Rachel Rosen
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

10.  Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Michael Kreuter; Svenja Ehlers-Tenenbaum; Karin Palmowski; Jacques Bruhwyler; Ute Oltmanns; Thomas Muley; Claus Peter Heussel; Arne Warth; Martin Kolb; Felix J F Herth
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.